0001683168-22-008718.txt : 20221230
0001683168-22-008718.hdr.sgml : 20221230
20221230170113
ACCESSION NUMBER: 0001683168-22-008718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221229
FILED AS OF DATE: 20221230
DATE AS OF CHANGE: 20221230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCLAUGHLIN JOHN
CENTRAL INDEX KEY: 0001203240
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 221502508
MAIL ADDRESS:
STREET 1: OCULUS INNOVATIVE SCIENCES, INC.
STREET 2: 1129 N. MCDOWELL BLVD.
CITY: PETALUMA
STATE: CA
ZIP: 94954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0306
4
2022-12-29
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001203240
MCLAUGHLIN JOHN
C/O SONOMA PHARMACEUTICALS, INC.
5445 CONESTOGA COURT, SUITE 150
BOULDER
CO
80301
1
0
0
0
Stock option (right to buy)
1.08
2022-12-29
4
A
0
20000
A
2032-12-29
Common Stock
20000
53252
D
The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control.
The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options.
/s/ Amy Trombly as attorney-in-fact
2022-12-30